Which actionable statements qualify as good practice statements In Covid-19 guidelines? A systematic appraisal

Dewidar, O; Lotfi, T; Langendam, M; Parmelli, E; Parkinson, ZS; Solo, K; Chu, DK; Mathew, JL; Akl, EA; Brignardello-Petersen, R; Mustafa, RA; Moja, L; Iorio, A; Chi, Y; Canelo-Aybar, C; Kredo, T; Karpusheff, J; Turgeon, AF; Alonso-Coello, P; Wiercioch, W; Gerritsen, A; Klugar, M; Rojas, MX; Tugwell, P; Welch, VA; Pottie, K; Munn, Z; Nieuwlaat, R; Ford, N; Stevens, A; Khabsa, J; Nasir, Z; Leontiadis, GI; Meerpohl, JJ; Piggott, T; Qaseem, A; Matthews, M; Schunemann, HJ

Schunemann, HJ (通讯作者)，McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada.

BMJ EVIDENCE-BASED MEDICINE, 2022; 27 (6): 361

Abstract

Objectives To evaluate the development and quality of actionable statements that qualify as good practice statements (GPS) reported in COVID-19 guidel......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索